Flovent HFA 220mcg and/or Equivalents
Flovent HFA 220mcg

Marketed as Flixotide Inhaler 250mcg in New Zealand
Manufactured by: Glaxosmithkline
This product is offered for sale by a Licensed Pharmacy located in New Zealand
From $0.65 USD/dose
CAN NOT BE SPLIT Must be taken in existing form.
No Generic Alternative Available
No generic alternative is available for this drug.
More Brand Products
Product | Lowest Unit Price |
---|---|
Flovent HFA 220mcg
Marketed as Flovent HFA 250mcg in Canada — Manufactured by: Glaxosmithkline |
$1.00 USD/dose |
Flovent HFA 220mcg
Marketed as Flixotide Inhaler 250mcg in New Zealand — Manufactured by: Glaxosmithkline |
$0.65 USD/dose |
Flovent HFA 220mcg
Marketed as Flixotide Inhaler 250mcg in Australia — Manufactured by: Glaxosmithkline |
$0.74 USD/dose |
Flovent HFA 220mcg
Marketed as Flixotide Evohaler 250mcg in the United Kingdom — Manufactured by: Glaxosmithkline |
$0.72 USD/dose |
No generic alternatives are available for this drug.
Flovent HFA and/or Equivalents warnings, side-effects and general information